Envista Holdings (NVST) Share-based Compensation (2018 - 2026)
Envista Holdings (NVST) posted quarterly Share-based Compensation of $6.0 million for Q2 2026, down 15.49% year-over-year from $7.1 million in Q2 2025, and down 69.7% quarter-over-quarter from $19.8 million in Q4 2025.
Envista Holdings (NVST) Share-based Compensation (2018 - 2026) Analysis & Trends
Envista Holdings' Share-based Compensation history runs 9 years deep, the most recent figure standing at $6.0 million for Q2 2026.
- In Q2 2026, Share-based Compensation fell 15.49% year-over-year to $6.0 million; the TTM figure through Apr 2026 stood at $23.7 million (up 2533.33% YoY), while the FY2025 annual figure was $24.8 million, up 367.92% from the prior year.
- Share-based Compensation for Q2 2026 stood at $6.0 million, down from $19.8 million in the prior quarter.
- The five-year high for Share-based Compensation was $41.1 million in Q3 2024, with the low at -$39.2 million in Q4 2024.
- The 5-year median for Share-based Compensation is $7.1 million (2025), against an average of $5.2 million.
- The sharpest annual moves came in 2022 and 2024: Share-based Compensation soared 10900.0% in 2022, then plunged 575.0% in 2024.
- Envista Holdings' Share-based Compensation stood at $21.6 million in 2022, then tumbled by 33.8% to $14.3 million in 2023, then plunged by 374.13% to -$39.2 million in 2024, then soared by 150.51% to $19.8 million in 2025, then tumbled by 69.7% to $6.0 million in 2026.
- Business Quant data shows NVST's Share-based Compensation at $6.0 million in Q2 2026, $19.8 million in Q4 2025, and $700000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Envista Holdings | 4.40 Bn | 3.27 Bn | 407.00 Mn | 11.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 11.60 Mn |
| Jul 3, 2026 | 11.60 Mn |
| Apr 3, 2026 | 6.00 Mn |
| Apr 3, 2026 | 6.00 Mn |
| Dec 31, 2025 | 19.80 Mn |
| Dec 31, 2025 | 19.80 Mn |
| Sep 26, 2025 | 700,000.00 |
| Sep 26, 2025 | 700,000.00 |
| Jun 27, 2025 | -2.80 Mn |
| Jun 27, 2025 | -2.80 Mn |
| Mar 28, 2025 | 7.10 Mn |
| Mar 28, 2025 | 7.10 Mn |
| Dec 31, 2024 | -39.20 Mn |
| Dec 31, 2024 | -39.20 Mn |
| Sep 27, 2024 | 41.10 Mn |
| Sep 27, 2024 | 41.10 Mn |
| Jun 28, 2024 | -8.10 Mn |
| Jun 28, 2024 | -8.10 Mn |
| Mar 29, 2024 | 11.50 Mn |
| Mar 29, 2024 | 11.50 Mn |